Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sag Visser"'
Autor:
S Rohou, JL Steimer, Thomas Kerbusch, Bengt Hamrén, O DellaPasqua, Jörg Lippert, Alexander Staab, C Tornøe, F Ivanow, Marylore Chenel, Lutz Harnisch, Sag Visser, V Cosson, Rolf Burghaus, N Frey, Scott Marshall, Peter A. Milligan, Sya Cheung
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. 5:93-122
This document was developed to enable greater consistency in the practice, application, and documentation of Model-Informed Drug Discovery and Development (MID3) across the pharmaceutical industry. A collection of "good practice" recommendations are
Autor:
Jewell RC; Clinical Pharmacology Modeling & Simulation, GSK, Durham, NC, USA., Mills RJ; Quantitative Pharmacology and Pharmacometrics, ICON Plc, Reading, UK., Farrell C; Quantitative Pharmacology and Pharmacometrics, ICON Plc, Reading, UK., Visser SAG; Clinical Pharmacology Modeling & Simulation, GSK, Collegeville, PA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct; Vol. 90 (10), pp. 2571-2581. Date of Electronic Publication: 2024 Jun 23.
Autor:
Vlasakakis G; GSK, Collegeville, Pennsylvania, USA., McCabe MT; GSK, Collegeville, Pennsylvania, USA., Ho YL; GSK, Collegeville, Pennsylvania, USA., Ferron-Brady G; GSK, Collegeville, Pennsylvania, USA., Martin P; Certara Drug Development Solutions, Sheffield, UK., Bentley D; Certara Drug Development Solutions, Sheffield, UK., Ellis C; GSK, Collegeville, Pennsylvania, USA., Antonysamy M; GSK, Collegeville, Pennsylvania, USA., Visser SAG; GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e70018.
Autor:
Weber B; NovoNordisk, Copenhagen, Denmark., Zineh I; Office of Clinical Pharmacology, US Food and Drug Administration, Silverspring, Massachusetts, USA., Lalonde R; University of Florida, Gainesville, Florida, USA., Visser SAG; Lansdale, Pennsylvania, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Jul; Vol. 17 (7), pp. e13880.
Autor:
Hooijmaijers R; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Parasrampuria R; GSK, Collegeville, Pennsylvania, USA., Marostica E; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Ferron-Brady G; GSK, Collegeville, Pennsylvania, USA., Post TM; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands., Visser SAG; GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Nov; Vol. 12 (11), pp. 1602-1618. Date of Electronic Publication: 2023 Sep 07.
Autor:
Turner DC; GSK, Collegeville, Pennsylvania, USA., Wada R; Certara, Menlo Park, California, USA., Zhou H; GSK, Collegeville, Pennsylvania, USA., Wang X; GSK, Collegeville, Pennsylvania, USA., de Greef R; Certara, Menlo Park, California, USA., Valiathan C; GSK, Collegeville, Pennsylvania, USA., Zhang L; Certara, Menlo Park, California, USA., Zhang N; Certara, Menlo Park, California, USA., Kuchimanchi M; GSK, Collegeville, Pennsylvania, USA., Chen TT; GSK, Collegeville, Pennsylvania, USA., Ballas M; GSK, Collegeville, Pennsylvania, USA., Visser SAG; GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Nov; Vol. 12 (11), pp. 1751-1763. Date of Electronic Publication: 2023 Jan 31.
Autor:
Visser SAG; Department of Quantitative Pharmacology & Pharmacometrics (QP2) at Merck & Co. Inc., Kenilworth, New Jersey, USA., Kandala B; Department of Quantitative Pharmacology & Pharmacometrics (QP2) at Merck & Co. Inc., Kenilworth, New Jersey, USA., Fancourt C; Department of Quantitative Pharmacology & Pharmacometrics (QP2) at Merck & Co. Inc., Kenilworth, New Jersey, USA., Krug AW; Department of Translational Pharmacology at Merck & Co. Inc., Kenilworth, New Jersey, USA., Cho CR; Department of Quantitative Pharmacology & Pharmacometrics (QP2) at Merck & Co. Inc., Kenilworth, New Jersey, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Jun; Vol. 107 (6), pp. 1296-1311. Date of Electronic Publication: 2020 Feb 03.
Autor:
Krishnaswami S; Pfizer, Groton, Connecticut, USA., Austin D; GSK, London, UK., Della Pasqua O; University College London, London, UK., Gastonguay MR; Metrum Research Group, Tariffville, Connecticut, USA., Gobburu J; University of Maryland, College Park, Maryland, USA., van der Graaf PH; Certara, Canterbury, UK., Ouellet D; Pfizer, Collegeville, Pennsylvania, USA., Tannenbaum S; Astellas, Northbrook, Illinois, USA., Visser SAG; GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Apr; Vol. 107 (4), pp. 762-772. Date of Electronic Publication: 2020 Feb 20.
Autor:
Venkatakrishnan K; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA., Zheng S; Janssen R&D, Spring House, Pennsylvania, USA., Musante CJ; Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts, USA., Jin JY; Genentech Inc., South San Francisco, California, USA., Riggs MM; Metrum Research Group, Tariffville, Connecticut, USA., Krishnaswami S; Pfizer Global Product Development, Groton, Connecticut, USA., Visser SAG; GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Jan; Vol. 107 (1), pp. 85-88. Date of Electronic Publication: 2019 Nov 21.
Autor:
Krug AW; Merck & Co., Inc., Kenilworth, New Jersey, USA., Visser SAG; Merck & Co., Inc., Kenilworth, New Jersey, USA., Tsai K; Merck & Co., Inc., Kenilworth, New Jersey, USA., Kandala B; Merck & Co., Inc., Kenilworth, New Jersey, USA., Fancourt C; Merck & Co., Inc., Kenilworth, New Jersey, USA., Thornton B; Merck & Co., Inc., Kenilworth, New Jersey, USA., Morrow L; Prosciento, Chula Vista, California, USA., Kaarsholm NC; Merck & Co., Inc., Kenilworth, New Jersey, USA., Bernstein HS; Merck & Co., Inc., Kenilworth, New Jersey, USA.; Vertex Pharmaceuticals, Boston, MA, USA., Stoch SA; Merck & Co., Inc., Kenilworth, New Jersey, USA., Crutchlow M; Merck & Co., Inc., Kenilworth, New Jersey, USA., Kelley DE; Merck & Co., Inc., Kenilworth, New Jersey, USA., Iwamoto M; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 Feb; Vol. 105 (2), pp. 417-425. Date of Electronic Publication: 2018 Sep 30.